Economic and clinical aspects of intravenous versus oral busulfan in adult patients for conditioning prior to HSCT

PURPOSE: Busulfan (BU) used as cytoreductive conditioning prior to hematopoietic stem cell transplantation (HSCT) is available as intravenous (IV) and oral (O) preparation. IV-BU has clinical advantages associated with relevant incremental costs. The aim was to determine the economic impact of IV-BU...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Karin, Schopohl, Dorothee, Rieger, Christina, Ostermann, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624833/
https://www.ncbi.nlm.nih.gov/pubmed/25773673
http://dx.doi.org/10.1007/s00520-015-2695-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624833/
https://www.ncbi.nlm.nih.gov/pubmed/25773673
http://dx.doi.org/10.1007/s00520-015-2695-8

Ejemplares similares